0001802369-20-000001.txt : 20200206 0001802369-20-000001.hdr.sgml : 20200206 20200205203839 ACCESSION NUMBER: 0001802369-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200206 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADARx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001802369 IRS NUMBER: 844145188 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359900 FILM NUMBER: 20580574 BUSINESS ADDRESS: STREET 1: 9880 CAMPUS POINT DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 608-345-9387 MAIL ADDRESS: STREET 1: 9880 CAMPUS POINT DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001802369 ADARx Pharmaceuticals, Inc. 9880 CAMPUS POINT DRIVE, SUITE 120 SAN DIEGO CA CALIFORNIA 92121 608-345-9387 DELAWARE None None Corporation true 2019 Zhen Li c/o ADARx Pharmaceuticals, Inc. 9880 Campus Point Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Director Rui Zhu c/o ADARx Pharmaceuticals, Inc. 9880 Campus Point Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-01-24 false true true true false 0 5000000 5000000 0 false 3 0 0 0 false ADARx Pharmaceuticals, Inc. /s/ Zhen Li Zhen Li President & CEO 2020-02-04